Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengtao Yuan

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Bio-Protocol|August 12, 2024
Determining the In Vitro Ligand-Target Interaction by Cellular Thermal Shift Assay and Isothermal Dose-Response Fingerprint AssayDanyu Du, Shengtao Yuan, Jing Xiong
International Journal of Molecular Sciences|March 11, 2023
Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer TherapyLiufeng Zhang, Yuancheng Wei, Shengtao Yuan, et al.
Journal of Biomolecular Screening|February 12, 2011
A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activityWenwen Jiang, Junping Kou, Shengtao Yuan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 18, 2017
PLOD2 in cancer researchHongzhi Du, Mao Pang, Xiaoying Hou, et al.
Oncology Reports|January 19, 2017
Synergistic combination of YS-1 and adriamycin inhibits human renal cancer through ERK1/2 signaling pathway in vitro and in vivoXiaowen Yu, Qingqing Yang, Sensen Lin, et al.
Cancer Letters|June 11, 2022
Metabolism and polarization regulation of macrophages in the tumor microenvironmentJia Wang, Shichao Mi, Muyao Ding, et al.
Current Drug Targets|February 23, 2018
Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor TherapyGhulam Jilany Khan, Li Sun, Sara Khan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2018
Plasminogen activator inhibitor-1 in cancer researchSijing Li, Xiaohui Wei, Jinyong He, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivativesYi Bi, Jinyi Xu, Xiaoming Wu, et al.
Investigational New Drugs|February 3, 2020
The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancerXiaofeng Gong, Danyu Du, Yanran Deng, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Bio-Protocol|August 12, 2024
Determining the In Vitro Ligand-Target Interaction by Cellular Thermal Shift Assay and Isothermal Dose-Response Fingerprint AssayDanyu Du, Shengtao Yuan, Jing Xiong
International Journal of Molecular Sciences|March 11, 2023
Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer TherapyLiufeng Zhang, Yuancheng Wei, Shengtao Yuan, et al.
Journal of Biomolecular Screening|February 12, 2011
A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activityWenwen Jiang, Junping Kou, Shengtao Yuan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 18, 2017
PLOD2 in cancer researchHongzhi Du, Mao Pang, Xiaoying Hou, et al.
Oncology Reports|January 19, 2017
Synergistic combination of YS-1 and adriamycin inhibits human renal cancer through ERK1/2 signaling pathway in vitro and in vivoXiaowen Yu, Qingqing Yang, Sensen Lin, et al.
Cancer Letters|June 11, 2022
Metabolism and polarization regulation of macrophages in the tumor microenvironmentJia Wang, Shichao Mi, Muyao Ding, et al.
Current Drug Targets|February 23, 2018
Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor TherapyGhulam Jilany Khan, Li Sun, Sara Khan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2018
Plasminogen activator inhibitor-1 in cancer researchSijing Li, Xiaohui Wei, Jinyong He, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivativesYi Bi, Jinyi Xu, Xiaoming Wu, et al.
Investigational New Drugs|February 3, 2020
The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancerXiaofeng Gong, Danyu Du, Yanran Deng, et al.
Pageof 11